Here are five new biologic device launches or releases in 2018 so far:
Kleiner Device Labs initiated a full commercial launch of its spinal bone graft delivery tool.
Spine Wave launched the GraftMag Graft Delivery System.
Royal Biologics introduced Amnio-Maxx, an amniotic stem cell product.
Aziyo Biologics launched OsteGro, an allograft bone matrix designed to support new bone growth in procedures.
NuVasive launched the AttraX Scaffold in the U.S. for use in the posterolateral spine to promote fusion.
More articles on biologics:
3 things to know about the NanoFuse Bioactive Matrix
NanoFuse Biologics adds orthobiologics executive: 3 insights